Randy Brenner
General Counsel chez PARATEK PHARMACEUTICALS, INC.
Profil
Randy Brenner is currently the Chief Development & Regulatory Officer at Paratek Pharmaceuticals, Inc. He previously worked at Pfizer Inc. as the Vice President-Established Products Business Units from 2010 to 2011.
He also worked at Shire Plc as the Head-Regulatory Affairs.
Mr. Brenner completed his undergraduate degree at Muhlenberg College and his graduate degree at Temple University School of Pharmacy.
Postes actifs de Randy Brenner
| Sociétés | Poste | Début |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | General Counsel | 03/06/2015 |
Anciens postes connus de Randy Brenner
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/09/2011 |
| SHIRE | Corporate Officer/Principal | - |
Formation de Randy Brenner
| Muhlenberg College | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
